Concepedia

Elisabetta Monaci

EM

15

Publications

1.9K

Citations

14

H-Index

2000

Active since

Affiliations

Novartis (Italy)(Current)

Novartis (Switzerland)

Sapienza University of Rome

University of Siena

University of Padua

Elisabetta Monaci is an author at Novartis (Italy) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

2000–2019

15

Publications

15

Molecular and cellular signatures of human vaccine adjuvants

Flaviana Mosca, Elaine Tritto, Alessandro Muzzi et al. · Proceedings of the National Academy of Sciences · 2008 · 490 citations · Full text

, , +20

The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells

Anja Seubert, Elisabetta Monaci, Mariagrazia Pizza et al. · The Journal of Immunology · 2008 · 421 citations · Full text

Rational design of small molecules as vaccine adjuvants

Tom Wu, Manmohan Singh, Andrew T. Miller et al. · Science Translational Medicine · 2014 · 175 citations

Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against <i>Staphylococcus aureus</i>

Fábio Bagnoli, Maria Rita Fontana, Elisabetta Soldaini et al. · Proceedings of the National Academy of Sciences · 2015 · 170 citations · Full text

, , +20

MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action

Elena Caproni, Elaine Tritto, Mario Cortese et al. · The Journal of Immunology · 2012 · 124 citations

, , +15

Rows per page

1–5 of 15